ANXA2 and cancer: Further investigations with additional cancer cell lines, primary cancer cells and in vivo models are necessary to identify specific clinical disease manifestations in which Annexin A2 and collagen-I interactions influence the cancer phenotype and could be targeted in the prevention of cancer progression.